Business Daily Media

The Times


.

Immuno Cure BioTech acquires Shanghai Teresa Healthcare

Integrating Electroporation Technology & DNA Vaccine Platforms

HONG KONG SAR - Media OutReach - 20 September 2022 - Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccines and immunotherapies, announced today the acquisition of 92.6% of Shanghai Teresa Healthcare, the pioneer of electroporation technology and device in China.

The transaction will be settled in cash and shares. Teresa's shareholders will swap for about 1.5% equity in Immuno Cure while the inventor of Teresa's EP technology, Professor XU Yuhong (徐宇虹), maintains her 7.4% direct equity in Teresa.

Teresa EP device delivers brief electrical pulses to promote efficient penetration of DNA vaccine through cell membrane for the enhancement of gene expression and ultimate immune responses. It is the only such device approved by National Medical Products Administration for the administration of DNA vaccine in China. Such EP technology has been an integral part of Immuno Cure's DNA vaccine delivery strategy from research to clinical stage.

Founded in 2004, Shanghai Teresa is an innovative medical device group focusing in electro immunotherapies and rehabilitation therapies. In 2005, Teresa's electroporation technology was developed to enhance the delivery of DNA medicine, based on the intellectual property generated by Shanghai Jiao Tong University under the National 863 Project. Such EP technology has been proven safe and efficacious after deployment of over 10,000 times in collaboration with more than thirty hospitals for the administration of DNA medicine in numerous human trial subjects.

Immuno Cure has two PD-1-Enhanced DNA vaccines currently in phase 1 clinical trial for prevention of COVID-19 and therapeutic cure of HIV/AIDS.

Dr JIN Xia, CEO of Immuno Cure said, "Immuno Cure has partnered with Teresa over the years in developing customised EP delivery strategy for our PD-1-Enhanced DNA vaccines, which has brought about encouraging results in clinical setting recently. I am pleased with this convergence with Teresa, which will no doubt bring our teams even closer together. Teresa will continue to operate independently while leveraging on Immuno Cure's R&D platform for the development of their next generation non-invasive EP technology for intradermal delivery strategy. Immuno Cure is committed to support the continual growth and success of Teresa."

Ms. CHEN Liye, CEO of Teresa said, "Founded on our long term collaboration, Teresa is excited to become a member of Immuno Cure Group. This move will not only provide us with a much closer R&D relationship, which is essential for our technology advancement but also offer us the financial capability to meet future needs. Teresa treasures our collaborations with other players in the field and look forward to continuing our collaborations with new and sustainable EP technology."

Professor CHEN Zhiwei, Director of AIDS Institute at the University of Hong Kong and the Principal Scientific Advisor of Immuno Cure said, "Our research and development work at the AIDS Institute and Immuno Cure has benefitted from Teresa's EP technology and their diligent collaborative effort over the past 12 years. I am pleased to see their relationship developing into an even closer tie. Look forward to the development of the next generation of EP technology for further optimisation of delivery strategy and patient experience."

Dr Percy CHENG, Chairman of Immuno Cure concludes, "This transaction offers Immuno Cure the opportunity to secure Teresa's EP technology for support of not only R&D but also the clinical administration of our PD-1-Enhanced DNA vaccines. We are pleased with Professor XU's decision to remain as our co-investor in Teresa and are optimistic in the future of EP technology in our DNA vaccine development."Hashtag: #ImmunoCureBiotech

The issuer is solely responsible for the content of this announcement.

Immuno Cure BioTech

Immuno Cure BioTech is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development of vaccines and immunotherapies for cancers, inflammatory and infectious diseases based on its patented PD-1-Enhanced DNA vaccine and Anti-Δ42PD1 Blocking Antibody technology platforms.

To learn more about Immuno Cure BioTech, please visit

Shanghai Teresa Healthcare

Founded in 2004, Shanghai Teresa is an innovative medical device group based in Shanghai Zhangjiang Hi-Tech Park, focusing in electro immunotherapies and rehabilitation therapies.

To learn more about Shanghai Teresa Healthcare, please visit




News from Asia

Huagui Group: A Global Player Across Two RMB100-Billion Aquatic Markets, as Honghu Lotus Root Ranks No. 1 in Antioxidant Content

HONGHU, CHINA – Media OutReach Newswire – 25 September 2026 – Honghu lotus root ranks first in antioxidant content among major lotus-root-producing regions, according to industrial report by China...

GrabSteel Enters into Committed Equity Facility of up to US$100 Million with White Lion Capital

Johor steel distributor, built to US$28 million without outside equity, arranges its first committed source of outside capital, available following a U.S. listing, to develop Matcon, a construction...

Angel Health Wan Chai Clinic Commences Operations, Providing General Practice, Health Check and Vaccination Services

HONG KONG SAR – Media OutReach Newswire – 25 September 2026 – Angel Health has commenced operations at the Wan Chai clinic, marking a further expansion of the medical service network...

Correcting and Replacing: Global Schools Group Marks 25th Anniversary with S$100,000 Multi-Organisation Community Support

The Group outlined ambitious global expansion with 20 new campuses by 2030 and next-generation student initiativesSINGAPORE – Media OutReach Newswire – 25 September 2026 – Global Schools Group (GS...

From Holiday Getaways to Meaningful Journeys: How Le Méridien Phuket Mai Khao Beach Resort Is Reshaping the Festive Season

PHUKET, THAILAND – Media OutReach Newswire – 25 September 2026 – As travellers increasingly seek meaningful ways to celebrate the festive season, Le Méridien Phuket Mai Khao Beach Resort is unvei...

MIHAS Reaffirms Malaysia’s Pivotal Role in the Growing Global Halal Economy

Flagship Halal Showcase Connects Exporters Across 58 Countries, Unifying Global Sourcing, Sector MoUs, and Industry Knowledge HubsKUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 25 September 20...

Amari Koh Samui and OZO Chaweng Samui invite active travellers to fill their trip with more of the experiences they love

BANGKOK, THAILAND – Media OutReach Newswire – 25 September 2026 – A race or sporting event may be the reason to pack a bag and set off, but the enjoyment of a trip need not end at the finish line...

Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe

AMSTERDAM, NETHERLANDS – Media OutReach Newswire – 26 September 2026 – On September 25, Green SM held a technical opening event in the Netherlands, marking the beginning of its high-quality pure-...

MIHAS Awards 2026 Celebrates Excellence and Sets New Benchmark for Innovation, Sustainability and Digitalisation Across the Global Halal Ecosystem

KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 26 September 2026 - The MIHAS Awards 2026, one of the key highlights of the Malaysia International Halal Showcase (MIHAS) 2026, concluded today a...

QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany

DÜSSELDORF, GERMANY – Media OutReach Newswire – 26 September 2026 – QUORRA X5, a micro-mobility robot, has made its global debut at REHACARE International 2026 – International Trade Fair for Rehab...

Customer Service Is Becoming Part of the Small Business Sales and Marketing Engine

For Customer Service Week, 5-9 October, Thryv is urging small businesses to look beyond generating  enquiries and examine what happens after a custome...

Gift Cards as the gateway to agentic payments

Prepaid and stored value gives consumers the trust and control to try AI shopping agents By Blackhawk Network VP Head of ANZ Kieran Nolan For deca...

Why Data Accumulation Without Governance Undermines Sustainability Goals

In July 2026, Group 2 entities, the second cohort of Australian businesses, began their first reporting period under the mandatory climate disclosur...

Permanent $20,000 Instant Asset Write-Off Gives Small Businesses Greater Planning Certainty

The Federal Government’s decision to permanently legislate the $20,000 instant asset write-off will give eligible small businesses greater certainty...

Selling a Small Business in Australia: Understanding the Capital Gains Tax Concessions

For many Australian business owners, selling a business represents the reward for years—sometimes decades—of hard work. Unlike employees who may bu...

Australian businesses lean into global strategic partnerships (GCCs) for next wave of outsourcing

The Australian corporate landscape is undergoing a fundamental transformation in how it sources talent and innovation. While businesses have traditi...